Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy
Clinical trial NCT02372578 · TERMINATED
Trial details
- NCT number
- NCT02372578
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-27
- Primary completion
- 2016-05-20
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.